VOR
NASDAQStockVor Biopharma Inc.
$13.51-0.54 (-3.84%)
52-Week Range
$3.03
$53.40
Key Stats
Market Cap
92.6M
P/E Ratio
—
Dividend Yield
—
Beta
2.04
Volume
531.0K
Avg Volume
681.1K
Performance
1M
+7.50%
3M
+4.00%
6M
-56.09%
YTD
+20.70%
1Y
-21.55%
3Y
-86.06%
5Y
-98.28%
Price Chart
ETF Exposure
VOR is held by 14 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| SURI | Simplify Propel Opportunities ETF | 0.45% |
| SBIO.L | Invesco NASDAQ Biotech UCITS ETF | 0.02% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.02% |
| BIB | ProShares - Ultra Nasdaq Biotechnology | 0.01% |
| VXF | Vanguard Extended Market ETF | 0.00% |
| ITOT | iShares Core S&P Total U.S. Stock Market ETF | 0.00% |
| XEQT.TO | iShares Core Equity ETF Portfolio | 0.00% |
| XUU.TO | iShares Core S&P U.S. Total Market Index ETF | 0.00% |
| VCNS.TO | Vanguard Conservative ETF Portfolio | 0.00% |
| VEQT.TO | Vanguard All-Equity ETF Portfolio | 0.00% |
| VRIF.TO | Vanguard Retirement Income ETF Portfolio | 0.00% |
| VTI | Vanguard Total Stock Market ETF | 0.00% |
| VUN.TO | Vanguard U.S. Total Market Index ETF | 0.00% |
| VUS.TO | Vanguard U.S. Total Market Index ETF (CAD-hedged) | 0.00% |
About VOR ETF Exposure
Vor Biopharma Inc. (VOR) is held by 14 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 92.6M, VOR is a widely held institutional stock. The stock currently trades at $13.51. Investors can gain exposure to VOR through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold VOR, sorted by portfolio weight.